| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 08/10/2006 | US20060178515 Tetrahydroisoquinolyl acetamide derivatives for use as orexin receptor antagonists |
| 08/10/2006 | US20060178436 Use of docosahexanoic acid as active substance for the treatment of lipodystrophy |
| 08/10/2006 | US20060178434 Butenoic acid derivatives processes for the preparation thereof pharmaceutical compositions comprising them and use for the treatment of dyslipidaemia atherosclerosis and diabetes |
| 08/10/2006 | US20060178432 Dyslipidemias, diabetes; (2S)-2-ethoxy-3-[4-(2-{4-[(methylsulfonyl)oxy]phenoxy}ethyl)phenyl]propanoic acid |
| 08/10/2006 | US20060178429 2-Phenyl-3-hydrogenated furanyl, pyranyl, thiophenyl or thiopyranyl-N-heteroaromatic propionamides, e.g., 2-(3,4-Dichloro-phenyl)-3-(tetrahydro-pyran-2-yl)-N-thiazol-2-yl-propionamide; compounds increase insulin secretion in the treatment of type II diabetes. |
| 08/10/2006 | US20060178418 For therapy of asthma, bronchial asthma, chronic obstructive pulmonary disease, allergic rhinitis, eosinophilic granuloma, nephritis, rheumatoid arthritis, cystic fibrosis, chronic bronchitis, multiple sclerosis, Crohns disease, psoraisis, uticaria, adult vernal conjunctivitis, |
| 08/10/2006 | US20060178417 4-[6(2,2-dimethylpropanoyloxy)indan-1-ylmethyl]1H-imidazole, an alpha 2 adrenergic agonist, for the treatment of hypertension, glaucoma, headaches, diarrhea, ischemia, drug abuse and dependence, hypotension, shock, congestive heart failure, anxiety, as decongestants, analgesics or as sedatives |
| 08/10/2006 | US20060178405 Non-insulin dependent diabetes; 7-[2-(5-methyl-2-phenyl-4-oxazole)ethoxyl]-2-oxo-2H-1-benzopyran-3-carboxylic acid methyl ester; insulin-sensitizing activities |
| 08/10/2006 | US20060178375 2-(1-Cyclopentylpiperidin-4-yloxy)-5-(4-cyanophenyl)pyrimidine, for example; exhibits histamine receptor H3 antagonist or inverse agonist activity and is useful for the treatment and/or prevention of obesity, diabetes, hormonal secretion abnormality, sleep disorders |
| 08/10/2006 | US20060178372 Therapeutic quinoline compounds |
| 08/10/2006 | US20060178365 Optionally oxidized 6-(2-(5-methylthio-2-pyrimidinyloxy)ethoxy)-2-phenylpyrimidin-4-yl-substituted sulfamides |
| 08/10/2006 | US20060178362 Substituted heterocyle fused gamma-carbolines |
| 08/10/2006 | US20060178356 Treating oxidative stress-related conditions typically responsive to cellular enzyme modulation with a substituted phenolic compound having unsaturated groups, e.g. 1-((3-methyl-5-oxo-2-pyrazolin-1-yl), 4-(3-methoxy-4-hydroxy-phenyl)-vinyl-)benzene; skin disorders; antiischemic and cardiotonic agents |
| 08/10/2006 | US20060178343 Hydroxypropylated starch; hyperlipidemia; visceral fat accumulation inhibitor, blood triglyceride level rise inhibitor |
| 08/10/2006 | US20060178336 Oral administration of therapeutic agent coupled to transporting agent induces tolerance |
| 08/10/2006 | US20060178317 Methods of increasing endogenous erythropoietin (EPO) |
| 08/10/2006 | US20060178316 Methods of increasing endogenous erythropoietin (EPO) |
| 08/10/2006 | US20060178315 For therapy of immune or autoimmune diseases |
| 08/10/2006 | US20060177543 Process for producing liquid formulation containing raw yeast and liquid formulation |
| 08/10/2006 | US20060177528 Formulation Of A Mixture Of Free-B-Ring Flavonoids And Flavans As A Therapeutic Agent |
| 08/10/2006 | US20060177499 Method for the manufacture of a pharmaceutical composition in the form of tablets containing a fibrate and tablets obtained according to the method |
| 08/10/2006 | US20060177443 Integrin antagonists |
| 08/10/2006 | US20060177432 Methods and reagents for protease inhibition |
| 08/10/2006 | CA2596973A1 Raf inhibitor compounds and methods |
| 08/10/2006 | CA2596854A1 Imidazole derivatives |
| 08/10/2006 | CA2596332A1 Anti-t cell and autoantigen treatment of autoimmune disease |
| 08/10/2006 | CA2595835A1 Chemical compounds |
| 08/10/2006 | CA2595770A1 Formulations and dosing regimen for ppar-alpha modulators |
| 08/10/2006 | CA2595409A1 Oral dosage form comprising rosiglitazone |
| 08/10/2006 | CA2593858A1 Antidiabetic bicyclic compounds |
| 08/10/2006 | CA2593749A1 Classes of compounds that interact with integrins |
| 08/09/2006 | EP1688487A1 Method of controlling transcription of insulin gene |
| 08/09/2006 | EP1688434A1 Antibody and use of the same |
| 08/09/2006 | EP1688430A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 08/09/2006 | EP1688418A2 Chemokine receptor antagonists and methods of use thereof |
| 08/09/2006 | EP1688148A1 Combination treatment using exendin-4 and thiazolidinediones |
| 08/09/2006 | EP1688140A1 Lipometabolism improver containing pine bark extract |
| 08/09/2006 | EP1688138A1 Receptor function regulating agent |
| 08/09/2006 | EP1687631A1 Methods for identifying compounds involved in the phosphoinositide-mediated signalling and use thereof in the manufacture of medicaments |
| 08/09/2006 | EP1687292A2 Vitamin d receptor modulators |
| 08/09/2006 | EP1687030A2 Combination of a dpp iv inhibitor and an anti-obesity or appetite regulating agent |
| 08/09/2006 | EP1687014A1 Use of additionally fermented distillers grains for preventing and/or treating increased blood sugar values |
| 08/09/2006 | EP1686996A1 Quinazolinone compounds with reduced bioaccumulation |
| 08/09/2006 | EP1686983A1 Use of pentadienoic acid derivates for treatement of hyperuricemia |
| 08/09/2006 | EP1686979A2 Activation of hypoxia-inducible gene expression |
| 08/09/2006 | EP1456351B1 New strain of lactic acid bacterium and edible compositions, drugs and veterinary products containing it |
| 08/09/2006 | EP1453832B1 Ring fused pyrazole derivatives |
| 08/09/2006 | EP1441730B1 Hydrazono-malonitriles |
| 08/09/2006 | EP1383483A4 Controlled delivery of tetracycline compounds and tetracycline derivatives |
| 08/09/2006 | EP1329456B1 Glucopyranosyloxybenzylbenzene derivatives and medicinal compositions containing the same |
| 08/09/2006 | EP1317453B1 Isoxazoles and their use as inhibitors of erk |
| 08/09/2006 | EP1246623B1 Compounds specific to adenosine a1, a2a, and a3 receptor and uses thereof |
| 08/09/2006 | EP1135135A4 Chk1 kinase inhibitors |
| 08/09/2006 | EP1012177B1 Estrogen receptor |
| 08/09/2006 | EP0988316B1 Methods and compositions for diagnosis and treatment of iron overload diseases and iron deficiency diseases |
| 08/09/2006 | EP0988301B1 Imidazolyl-cyclic acetals |
| 08/09/2006 | CN1816551A Pyrrolopyrimidine a2b selective antagonist compounds, their synthesis and use |
| 08/09/2006 | CN1816550A Indolyl derivatives substituted with a thiazole ring and their use as ppar modulators |
| 08/09/2006 | CN1816549A Inhibitors of phosphatidylinositol 3-kinase |
| 08/09/2006 | CN1816546A Benzenesulfonylamino compounds and pharmaceutical compositions containing these compounds |
| 08/09/2006 | CN1816542A 2,4-bis (trifluoroethoxy)pyridine compound and drug containing the compound |
| 08/09/2006 | CN1816536A Regulator of cannabinoid receptor |
| 08/09/2006 | CN1816355A Tablet and process for producing the same |
| 08/09/2006 | CN1816353A Medicinal composition for preventing or treating Th1 type immunological disease |
| 08/09/2006 | CN1816345A Preventive and/or remedy for diseases accompanied by tissue destruction |
| 08/09/2006 | CN1816334A Use of sulfonamide derivatives as ligands for 5-ht6, in treatment of e.g. food ingestion disorder, obesity, bulimia, anorexia, cachexia and type ii diabetes |
| 08/09/2006 | CN1816329A Combination comprising S-[2-([[1-(2-ethylbutyl)cyclohexyl]carbonyl]amino)phenyl]2-methylpropanethioate and an HMG COA reductase inhibitor |
| 08/09/2006 | CN1814599A Thiazolidinedione derivative and its use as antidiabetic |
| 08/09/2006 | CN1814300A Glinide drug adjuvant composition and method for preparing drug containing same |
| 08/09/2006 | CN1814290A Multi-layer tablet containing calsium-path receptor retarder and ACE inhibitor, and preparing method |
| 08/09/2006 | CN1814280A Regenerated human blood-platelet derivative growth factor gel |
| 08/09/2006 | CN1814262A Medicine for treating diabetes and preparing method |
| 08/09/2006 | CN1814235A Fat-reducing slimming instant powder |
| 08/09/2006 | CN1814197A Use of alpha-amylase inribitor in medicine for preventing and treating hyper lipermia and athereosclerosis |
| 08/09/2006 | CN1814167A Health-care for diabetes |
| 08/09/2006 | CN1814149A Medicine composition for treating diabetes or diabetes kidney-disease, and preparing method |
| 08/09/2006 | CN1814123A Chinese medicine composition for treating diabetes and its use |
| 08/09/2006 | CN1814119A Yougui capsule |
| 08/09/2006 | CN1814094A Fat-reducing health-care product |
| 08/09/2006 | CN1814091A External-use Chinese medicine preparation for treating angeitis and diabetes foot |
| 08/09/2006 | CN1814079A Method for preparing compound micron pini-konnjaku juice fat-reducing sugar-reducing oral liquor |
| 08/09/2006 | CN1814078A Fat-reducing sugar-reducing granules of compound micron pini and konnjaku, capsule and tablet preparing method |
| 08/09/2006 | CN1814075A Fat-reducing liver-protecting medicine and preparing method |
| 08/09/2006 | CN1814042A Yanyou Chinese medicine preparation and preparing method |
| 08/09/2006 | CN1814040A Compound liquid capsule of Chinese caterpillar fungus, preparing method and quality control method |
| 08/09/2006 | CN1813968A Chines medicine remedy for treating hypevlipermia and cerebrovascular and cardlovascular disease and preparing method |
| 08/09/2006 | CN1813957A Medicine composition for treating diabetes and preparing method |
| 08/09/2006 | CN1813940A Weight-reducing jelly |
| 08/09/2006 | CN1813937A Compound formulation for treating hyperlipidemia and its preparing method |
| 08/09/2006 | CN1813920A Medicinal composition with synergistic effect |
| 08/09/2006 | CN1813910A Medicinal composition with blood sugar reducing action and its preparing method |
| 08/09/2006 | CN1813876A Xian Pengliaofu oral preparation-a Chinese medicine for treating bone disease |
| 08/09/2006 | CN1813873A Medicine for treating diabete peripheral herve pathology |
| 08/09/2006 | CN1813863A Functional food with blood sugar reducing action and its preparing method |
| 08/09/2006 | CN1813858A Method for preparing oral liquid of several micron powders for reducing blood sugar and anti-fatigue |
| 08/09/2006 | CN1813857A Method for preparing particle, capsule and tablet of several miccron powders for reducing blood sugar and anti-fatigue |
| 08/09/2006 | CN1813822A Natural medicinal composition for preparing diabete drug |
| 08/09/2006 | CN1813818A Soft capsule for reducing blood fat and its preparing method |
| 08/09/2006 | CN1813803A Method for preparing natural biocalcium product utilizing mussel shell |
| 08/09/2006 | CN1813795A Medicinal composition |